The global most powerful information hub of high performance & advanced materials, innovative technologies

to market your brand and access to the global demand and supply markets

Global Leading 4K Ultra HD Fluorescence Endoscopic Navigation System manufacturer Hay:P11GDOP

GDOP Medical Device Technology Inc. is a high-tech company committed to providing high-performance medical devices and services utilizing cutting-edge optical and bio-optical technologies in the medical field.


GDOP was founded by a coalition of multidisciplinary experts in medical, biomedical, engineering, quality assurance as well as regulatory affairs. Dedicated to technological innovations, It provides customers with an array of high-end medical devices, among which the intraoperative endoscopic fluorescence navigation system has become a global leader and been widely used across many departments in general surgery.

It has subsidiaries or R&D labs in Suzhou, Beijing, Changsha, Wuhan, and aspires to be at the forefront of medical technology development through multidisciplinary collaborations with renowned research and clinical institutions including Tsinghua University, Suzhou Institute of Biomedical Engineering and Technology, Chinese Academy of Sciences, Peking University School of Pharmaceutical Sciences and tier-1 teaching hospitals in China.


In July 2020, GDOP launched the world's first 4K fluorescence laparoscopic system, marking that the fluorescence navigation endoscope independently developed by the company has reached the world's leading level.


GDOP is a platform company that applies aerospace optics technology and engineering experience to the field of medical endoscopes. The product line covers white light/fluorescence navigation cavity mirror system, soft mirror system, disposable mirror system, as well as supporting equipment, fluorescent developer, etc. With its leading technology and excellent cost performance, GDOP has been widely recognized by users; nearly one-third of the top 100 hospitals in China have purchased GDOP products, and the market share of fluorescent navigation endoscopes in China is nearly 50%.


4K Fluorescence Navigation Endoscope System


Traditional surgical treatment is done through open surgery, which is inevitable to deal with the problems of "large wounds, more bleeding, and slow recovery". How to reduce the damage to the patient during the operation is a difficult problem to be solved urgently.


The innovation of laparoscopic technology has made it possible to make surgery minimally invasive. While the reduction of the incision has reached its limit, the superiority of "small trauma, light pain, and quick recovery" is demonstrated. In recent years, the emergence of high-tech "intraoperative marking" and "fluorescence navigation function" has made it possible to "precisely locate the tumor boundary" and "observe tissue blood perfusion" and "track the lymphatic system in real time." The fluorescent navigation system for laparoscopic surgery is equivalent to the "Beidou navigation system" for surgeons, making the operation more accurate, thorough, safe and reliable. At the beginning of the year, the global endoscopy giant Olympus acquired Quest (the Dutch photonics equipment company) once again demonstrated that the replacement of a single white light endoscopy with fluorescence laparoscopy is a major historical trend.


In recent years, the field of endoscopy has shown a trend of rapid development, and the international mainstream market has maintained a double-digit annual growth; China, as the world's largest potential endoscopy market, has a market size of nearly RMB 30 billion and a compound growth rate of more than 17%. It is estimated that China's domestic mirror market will exceed 40 billion yuan in 2024. However, the endoscope system has high technical requirements for light, machinery, electricity, and arithmetic, and there are technical closed-loop barriers. Therefore, the global market has long been monopolized by foreign giants such as Storz, Olympus, and Stryker. Although domestic brands have been working hard for more than ten years, more than 90% of the domestic market is still firmly occupied by these international giants, and the market share of domestic brands is still very low.


Faced with the situation that more than 90% of the minimally invasive surgery field has relied on imported manufacturers in the past ten years, GDOP has established a technical route to apply the world's leading optical technology to the medical field at the beginning of its establishment. In accordance with the layout of "production, learning, and research", and at the same time cooperating with China's top technology research institutes and top tertiary hospitals, it has the core capabilities of independent research and development of "optical, mechanical, electrical, and computing" technologies, from design concepts to differentiated technical characteristics , Independent intellectual property rights, etc., followed its own original product route, and finally achieved a milestone achievement in which the navigation endoscopy system in fluoroscopy reached the world's leading level and the core products gradually realized import substitution.

In the future, GDOP will focus on the research and development of minimally invasive innovative iterative products to provide clinicians with more powerful emerging technology products. On the highly competitive track of endoscopy, Opumandi will rely on the world’s leading optical technology R&D team to continuously accelerate the development of innovative products based on the launch of the world’s first certification for “4K fluorescence” laparoscopy. Apply a deep understanding of pain points, create high-performance products, and accelerate the full realization of import substitution and internationalization.

Please check the message before sending